CareFusion Gets Exclusive 5-Year Deal for ResMed Ventilators

Xconomy San Diego — 

Two of San Diego’s biggest medical device companies, CareFusion (NYSE: CFN) and ResMed (NYSE: RMD), today announced a five-year agreement that gives CareFusion exclusive rights to distribute two ResMed non-invasive ventilators and accessories in the United States.

ResMed said the deal enables it to use CareFusion’s extensive sales network of U.S. hospitals, long-term acute care and skilled nursing facilities to launch its ResMed Stellar product line.

While ResMed ventilators have been available in Europe and Asia, the company was previously selling just its sleep apnea equipment in the United States, according to The San Diego Union-Tribune. The newspaper also noted that CareFusion CEO Kieran Gallahue resigned less than six months ago as the CEO at ResMed.